Keyphrases
Acute Lymphoblastic Leukemia
100%
Standard Risk
100%
Methotrexate
100%
Systemic Clearance
100%
Influence Probability
100%
Methotrexate Clearance
66%
Clinical Significance
33%
Working Diagnosis
33%
Complete Remission
33%
Statistical Analysis
33%
High Probability
33%
Prognostic Factors
33%
Drug Clearance
33%
Hemoglobin Level
33%
Treatment Protocol
33%
Relapse Risk
33%
Intermediate Dose
33%
White Blood Cell Count
33%
Mercaptopurine
33%
Kaplan-Meier Curve
33%
Oral Therapy
33%
Low-dose Methotrexate
33%
Multivariate Cox Regression Analysis
33%
Induction Treatment
33%
Nursing and Health Professions
Acute Lymphoblastic Leukemia
100%
Methotrexate
100%
Proportional Hazards Model
16%
Hemoglobin Blood Level
16%
Remission
16%
Leukocyte Count
16%
Kaplan Meier Method
16%
Mercaptopurine
16%
Drug Clearance
16%
Low Drug Dose
16%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
100%
Methotrexate
100%
Leukocyte
16%
Cell Count
16%
Proportional Hazards Model
16%
Low Drug Dose
16%
Mercaptopurine
16%
Kaplan Meier Method
16%
Drug Clearance
16%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Methotrexate
100%
Remission
16%
Mercaptopurine
16%
Immunology and Microbiology
Methotrexate
100%
Low Drug Dose
16%
Leukocyte Count
16%
Hemoglobin Blood Level
16%
Drug Clearance
16%
Veterinary Science and Veterinary Medicine
Methotrexate
100%
Leukocyte
16%